---
phase: 30-eye-safety-ledger-and-closeout
status: passed
verified: 2026-07-13
---

# Phase 30 Final Verification

full_suite_tests: 178

## Result

Phase 30 passed from independent implementation, renderer, boundary, promotion, blueprint, root-contract, quality, project, GSD, and work-ledger evidence. Command details are in `30-EYE-SAFETY-EVIDENCE.md`.

## Requirement Verdicts

| Requirement | Result | Evidence |
| --- | --- | --- |
| EYE-04 | passed | Positive-only and signed normalization, abnormal inputs, exact caps, warnings, and aggregate metrics passed. |
| EYE-05 | passed | Missing, reused, stale, public no-face, non-eye reuse, and redaction evidence passed. |
| EYE-06 | passed | Six direction-specific and one all-eye combined-weakening cases passed. |
| EYE-07 | passed | Public/SPI, active-root, import, network/cloud, commercial, inventory, VIP, and artifact gates passed. |
| EYE-08 | passed | Exactly four evidence-backed rows promoted atomically while the eye branch remains partial. |
| DOC-01 | passed | Blueprint, root, quality, project, planning, validation, and work-ledger owners passed independent guards. |

## Decision Coverage

| Decision | Verified outcome |
| --- | --- |
| D-01 | Negative `eyeSize` becomes a silent zero no-op. |
| D-02 | Negative `eyeTailLift` becomes a silent zero no-op. |
| D-03 | `eyeDistance` and `eyeYPosition` preserve both signs. |
| D-04 | Every field/direction has an independently asserted exact cap. |
| D-05 | Cap warnings and exact aggregate counts are asserted. |
| D-06 | Twelve non-finite field/value cases become zero. |
| D-07 | Reused eyes skip and zero without eye-only points. |
| D-08 | Stale eyes skip and zero with a distinct category reason. |
| D-09 | Reused face shape, nose, and mouth retain scale 0.5. |
| D-10 | Either missing eye group skips the complete eye domain. |
| D-11 | Fixed category messages and aggregate metadata pass disclosure guards. |
| D-12 | Resolver/provider plus public no-face layers pass. |
| D-13 | Six visible directions weaken and preserve signs. |
| D-14 | The all-eye multi-domain case records exactly six weakened fields. |
| D-15 | Named focused tests and the observed canonical suite count are durable. |
| D-16 | Full SDK, renderer build/run, 161/161 outputs, and 36/36 comparisons pass. |
| D-17 | Fail-closed active-source scans and exact VIP classification pass. |
| D-18 | No active boundary violation remains; `unclassified_matches: 0`. |
| D-19 | Only `大小`, `上下`, `眼距`, and `眼尾上扬` are implemented. |
| D-20 | Branch-level `眼睛` remains partial with future gaps explicit. |
| D-21 | Each owning document passes its bounded invariant, evidence-link, privacy, no-overclaim, and diff guard. |

## Observed Commands and Classifications

- Seven focused suites passed with 7, 12, 6, 13, 7, 9, and 7 observed tests respectively; the full SDK suite passed with the canonical count above.
- `BeautyExampleRenderer` built and ran successfully for 23 cases across 7 fixtures and produced 161 ignored outputs.
- The Phase 29 helper regression passed 161/161 outputs, 36/36 comparisons, same-dimension checks, and representative no-face output presence.
- Public/SPI raw geometry candidates, forbidden internal imports, API-shaped network/cloud paths, StoreKit/entitlement execution paths, new public eye fields, and tracked generated artifacts were zero.
- Exactly two static VIP occurrences were independently allowlisted; `unclassified_matches: 0`.
- Review status is clean; security is verified with zero open threats. No Demo build was required because Demo source did not change.

## Documentation and Atomic Guards

- The atomic ledger guard proves exactly four implemented eye rows and no other promoted eye row.
- `FEATURE_MATRIX.md` preserves branch-level `眼睛` as partial.
- Every blueprint, root contract, quality/project ledger, and GSD/work artifact passed a per-file bounded section or exact-row gate and links the detailed evidence.
- Decision coverage passed 21/21 and generated output/gallery files remain untracked.

## Non-Claims

Phase 30 does not claim whole eye-branch completion, new public fields, Demo UI changes, device evidence, commercial visual approval, broad reference parity, packaging, launch readiness, or committed generated image baselines.

## Verdict

Passed. The scoped four-row v1.6 eye slice is ready for milestone audit; milestone audit and archive remain separate workflows.

## Independent Goal Audit (2026-07-13)

**Status:** `passed`

**Score:** 9/9 v1.6 requirements accounted for; 6/6 Phase 30 requirements achieved.

This verification was rechecked against current source, tests, renderer inventory, blueprint rows, and planning traceability rather than inferred from the seven plan summaries.

### Actual-code evidence

- `BeautyParameters` uses positive-only `clampUnit` for `eyeSize` and `eyeTailLift`, signed `clampSigned` for `eyeDistance` and `eyeYPosition`, and still exposes exactly 31 stored fields under the passing inventory test.
- `BeautyEffectResolver` uses `capUnit` for size/tail and `capSigned` for distance/Y. Its current missing/reused/stale paths zero all four eye strengths, increment only aggregate skipped-eye metadata, and emit the fixed category messages asserted by tests.
- Current tests contain the required abnormal-input matrix, six exact cap/direction cases, two positive-only negative no-ops, either-eye missing coverage, reused/stale eye skip coverage with retained non-eye reuse reduction, public no-face extent/redaction coverage, six direction-specific combined weakening cases, and one exact six-field aggregate case.
- A fresh `swift test --package-path BeautySDK` run completed successfully with 178 tests and zero failures. This independently reconfirms the canonical `full_suite_tests: 178` value.
- The renderer source and renderer inventory test contain exactly the six Phase 29 eye cases used by EYE-01 through EYE-03. Phase 29's committed verifier/evidence remains the owner of the 161/161 output and 36/36 comparison observations; Phase 30 does not relabel those historical command observations as newly generated evidence.
- `SHAPE_FEATURE_LEDGER.md` marks exactly `大小`, `上下`, `眼距`, and `眼尾上扬` implemented under `眼睛`; all other eye subtools remain future. `FEATURE_MATRIX.md` keeps the `眼睛` branch `partial` and names the same four implemented subtools.
- Current generated output/gallery roots contain no tracked files. The public model remains limited to the existing four eye fields, and the Phase 30 security evidence records zero raw-geometry, forbidden-import, network/cloud, commercial-execution, and unclassified VIP candidates.

### v1.6 traceability audit

| Requirement | Owner | Current accounting |
| --- | --- | --- |
| EYE-01 | Phase 29 | Six public-facade renderer cases remain in renderer source and inventory tests; requirement and traceability rows are complete. |
| EYE-02 | Phase 29 | The committed helper and Phase 29 verification own the 161/161 existence/dimension and 36/36 portrait comparison evidence; requirement and traceability rows are complete. |
| EYE-03 | Phase 29 | Output/gallery paths remain ignored and untracked; requirement and traceability rows are complete. |
| EYE-04 | Phase 30 | Current normalization, resolver code, focused tests, and fresh full-suite run satisfy the cap/input goal. |
| EYE-05 | Phase 30 | Current resolver/provider/facade code and degradation/redaction tests satisfy the fail-safe goal. |
| EYE-06 | Phase 30 | Current combined-effect tests cover all six visible directions plus the aggregate case. |
| EYE-07 | Phase 30 | Boundary/security evidence is closed with `threats_open: 0` and no contradictory current source or inventory finding. |
| EYE-08 | Phase 30 | Exact four-row promotion is present; no fifth eye row is implemented. |
| DOC-01 | Phase 30 | Blueprint, root, quality, project, requirements, roadmap, state, validation, and work ledgers remain synchronized while branch status stays partial. |

### Must-have and non-claim result

All Plan 30-01 through 30-07 must-have truths are represented by current behavior or bounded documentation state. The source/test findings agree with the evidence, review is `clean`, security is `verified` with `threats_open: 0`, and validation retains all fifteen task rows as passed. No evidence was found for a forbidden overclaim: Phase 30 still excludes whole-eye completion, new public fields, Demo UI changes, device evidence, commercial visual approval, broad reference parity, packaging, launch readiness, and committed generated baselines.

No human-only acceptance gate remains for the scoped phase goal. Device/commercial/broad-parity review is explicitly future scope rather than incomplete Phase 30 acceptance.
